User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Needle biopsy of hepatocellular carcinoma - Assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes

Primary tabs

Chapel, F Guettier, C. Chastang, C. Rached, AA Mathieu, D. Trinchet, JC.

BACKGROUND. Although many studies concerning the prognostic factors of resected hepatocellular carcinoma have been performed, the prognostic information provided by needle biopsy of these tumors has not yet been extensively studied. METHODS. One hundred twenty-four white patients with histologically-confirmed hepatocellular carcinoma were entered into a prospective study from 1990 to 1992 with followed-up through October 1994. Most of the patients had cirrhosis (79%). Patients were classified according to Okuda's staging: Stage I (50%), Stage II (47%), and Stage III (3%). The one-year survival rate was estimated at 58% in Okuda's Stage I, and 15% in Stages II and III. Edmondson's grading, mitotic index, and proliferating cell nuclear antigen labeling index were studied on each biopsy. Univariate and multivariate analyses were performed to determine the prognostic significance of the different parameters. RESULTS. According to Edmondson's criteria, 13 of the hepatocellular carcinomas were Grade I, 63 Grade II, 42 Grade III, and 6 Grade IV. There was a significant correlation between Edmondson's grade, mitotic index, and proliferating cell nuclear antigen labeling index (P < 0.01). Univariate analysis showed both the histologic grade (P < 0.001) and mitotic index (P < 0.05) correlated with survival. Cox's model indicated that Edmondson's grading yields additional prognostic information for Okuda's staging (P < 0.001). The one-year survival rate for Okuda's Stage I was 76% for Edmondson's Grades I + II versus 23% for Grades III + IV. CONCLUSIONS. Edmondson's grading appears to be an important prognostic parameter for patients with hepatocellular carcinoma, and could help stratify patients for clinical trials. (C) 1996 American Cancer Society.

Document type Article de périodique (Journal article) – Article de recherche
Publication date 1996
Language Anglais
Journal information "Cancer" - Vol. 77, no. 5, p. 864-871 (1996)
Peer reviewed yes
Publisher Wiley-liss (New York)
issn 0008-543X
e-issn 1097-0142
Publication status Publié
Affiliation UCL
Keywords hepatocellular carcinoma ; prognosis, survival ; Edmondson's grade ; mitotic index ; proliferating cell nuclear antigen ; Okuda's stage ; Cox's model
Links
  1. Adachi, Cancer, 72, 2902 (1993)
  2. Haratake, Cancer, 72, 1178 (1993)
  3. Kitamoto, Cancer, 72, 1859 (1993)
  4. Higuchi, Cancer, 73, 2259 (1994)
  5. Ng, Cancer, 73, 2268 (1994)
  6. Isobe, J Clin Gastroenterol, 17, 350 (1993)
  7. Nakamuta, J Clin Ultrasound, 21, 551 (1993)
  8. Edmondson, Cancer, 7, 462 (1954)
  9. Mathews, Nature, 309, 374 (1984)
  10. Bravo, Nature, 326, 515 (1987)
  11. Dodd Roger Y., Hepatitis C Virus, Antibodies, and Infectivity:Paradox, Pragmatism, and Policy, 10.1093/ajcp/97.1.4
  12. Hall, J Pathol, 162, 285 (1990)
  13. Taylor, Hum Pathol, 25, 263 (1994)
  14. Okuda, Cancer, 56, 918 (1985)
  15. Grouped'Etude et de Traitement du Carcinome Hépatocellulaire, N Engl J Med, 332, 1256 (1995)
  16. Kaplan, J Am Stat Assoc, 53, 457 (1958)
  17. Cox, J R Stat Soc [B], 34, 187 (1972)
  18. Quinn, J Pathol, 160, 93 (1990)
  19. Hilsenbeck, Hum Pathol, 23, 601 (1992)
  20. Tarao, Cancer, 68, 1789 (1991)
  21. Melchiorri, Cancer, 74, 1713 (1994)
  22. Okada Shuichi, Shimada Kazuaki, Yamamoto Junji, Takayama Tadatoshi, Kosuge Tomoo, Yamasaki Susumu, Sakamoto Michiie, Hirohashi Setsuo, Predictive factors for postoperative recurrence of hepatocellular carcinoma, 10.1016/0016-5085(94)90419-7
  23. Cattoretti, J Pathol, 168, 357 (1992)
  24. O'Janguren, Human Pathol, 24, 905 (1993)
  25. Taniai, J Gastroenterol Hepatol, 8, 420 (1993)
  26. Terada, Cancer, 70, 591 (1992)
  27. Nakajima, J Gastroenterol, 29, 450 (1994)
  28. Nishimori, J Gastroenterol Hepatol, 9, 425 (1994)
  29. Patriarca, J Hepatol, 171, 5 (1993)
  30. Suehiro, Cancer, 76, 399 (1995)
  31. Al-Sheneber, Cancer, 71, 1954 (1993)
  32. Mayer, Cancer, 71, 2454 (1993)
  33. Yonemura, Cancer, 71, 2448 (1993)
  34. Tanaka, J Surg Oncol, 57, 57 (1994)
  35. Mangham, J Clin Pathol, 47, 473 (1994)
  36. McCormick, Histopathology, 21, 591 (1992)
  37. Galand, Cell Tissue Kinet, 22, 383 (1989)
  38. Celis, Proc Natl Acad Sci USA, 82, 3262 (1985)
  39. Mancini Raniero, Marucci Luca, Benedetti Antonio, Jezequel Anne-Marie, Orlandi Francesco, Immunohistochemical analysis of S-phase cells in normal human and rat liver by PC10 monoclonal antibody, 10.1111/j.1600-0676.1994.tb00048.x
  40. Hall PA, Coates PJ, Goodlad RA, Hart IR, lane DP, Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo, 10.1038/bjc.1994.287
  41. Ehrenpreis Eli D., Patterson Bruce K., Brainer James A., Yokoo Hidejiro, Rademaker Alfred W., Glogowski Walter, Noskin Gary A., Craig Robert M., Histopathologic Findings of Duodenal Biopsy Specimens in HIV-infected Patients With and Without Diarrhea and Malabsorption, 10.1093/ajcp/97.1.21
  42. Garcia, Am J Pathol, 134, 733 (1989)
  43. Harrison, J Pathol, 171, 115 (1993)
  44. Sabattini, J Pathol, 169, 397 (1993)
  45. Lynch, J Clin Pathol, 47, 122 (1994)
  46. Benjamin, Am J Surg Pathol, 15, 764 (1991)
  47. Koukoulis, J Pathol, 166, 359 (1992)
  48. Burford-Mason, Arch Pathol Lab Med, 118, 1007 (1994)
  49. Weidner, Am J Surg Pathol, 17, 987 (1993)
  50. Weidner, Hum Pathol, 25, 337 (1994)
  51. Van Diest, Hum Pathol, 23, 603 (1992)
  52. Stevens W R, Johnson C D, Stephens D H, Batts K P, CT findings in hepatocellular carcinoma: correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade., 10.1148/radiology.191.2.8153335
  53. Ikeda, Cancer, 71, 19 (1993)
  54. Torii, J Surg Oncol, 54, 13 (1993)
  55. Nzeako, Cancer, 76, 579 (1995)
  56. Lai, Hepatology, 11, 815 (1990)
  57. Arii, Cancer, 69, 913 (1992)
  58. The Liver Cancer Study Group of Japan, Cancer, 74, 2772 (1994)
  59. Izumi Ryohei, Shimizu Kohichi, II Tohru, Yagi Masao, Matsui Osamu, Nonomura Akitaka, Miyazaki Itsuo, Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection, 10.1016/0016-5085(94)90707-2
  60. Vauthey, Gastroenterology, 108, 617 (1995)
  61. Calvet, Hepatology, 12, 753 (1990)
Bibliographic reference Chapel, F ; Guettier, C. ; Chastang, C. ; Rached, AA ; Mathieu, D. ; et. al. Needle biopsy of hepatocellular carcinoma - Assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. In: Cancer, Vol. 77, no. 5, p. 864-871 (1996)
Permanent URL http://hdl.handle.net/2078.1/47610